Mon, 03/11/2024 - 13:03 |
Jensen |
Abascal |
jensenabascal@g.ucla.edu |
(310) 266-8937 |
Session 3: Immuno-oncology |
In situ vaccination with Flt3l gene modified CD103+ type 1 conventional dendritic cells synergizes with anti-PD-1 checkpoint blockade in murine models of non-small cell lung cancer |
Jensen |
Abascal |
Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Molecular Biology Institute, UCLA. |
- First Name: Raymond
Last Name: Lim Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA. - First Name: Ramin
Last Name: Salehi Rad Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California. VA Greater Los Angeles Health Care Center, Los Angeles, California - First Name: Zhe
Last Name: Jing Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California. - First Name: Michael
Last Name: Oh Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Molecular Biology Institute, UCLA; - First Name: William
Last Name: Crosson Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA. - First Name: Bitta
Last Name: Kahangi Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Molecular Biology Institute, UCLA. - First Name: Edgar
Last Name: Perez Reyes Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Molecular Biology Institute, UCLA. - First Name: Camelia
Last Name: Dumitras Affiliation: Jonsson Comprehensive Cancer Center, Los Angeles, California. - First Name: Diana
Last Name: Reyimjan Affiliation: Jonsson Comprehensive Cancer Center, Los Angeles, California. - First Name: Linh
Last Name: Tran Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California. - First Name: Manash
Last Name: Paul Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California. - First Name: Kostyantyn
Last Name: Krysan Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California. - First Name: Bin
Last Name: Liu Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California. - First Name: Steven
Last Name: Dubinett Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Department of Pathology and Laboratory Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California. VA Greater Los Angeles Health Care Center, Los Angeles, Ca
|
Abstract_Submission.pdf |
|
No |
Approved to be a Poster Presenter |
|
|
|
Mon, 03/11/2024 - 13:12 |
Esra |
Akbay |
esra.akbay@utsouthwestern.edu |
2146484159 |
Session 1: Oncogene-driven lung cancers and resistance to targeted therapies |
Kras G12D inhibition causes tumor regression and synergizes with immune checkpoint blockade in immunogenic lung cancer models |
Esra |
Akbay |
UT Southwestern Medical Center |
|
Abstract_Submission.pdf |
|
No |
Approved to be a Poster Presenter |
|
|
|
Mon, 03/11/2024 - 13:59 |
Mustafa |
Al-Dulaimi |
mustafa_al-dulaimi@dfci.harvard.edu |
12087180181 |
Session 6: Cancer Biology |
CDK8/19 Co-inhibition Enhances Osimertinib Efficacy in EGFR Mutant Non-Small Cell Lung Cancers (NSCLC) |
Mustafa |
Al-Dulaimi |
DFCI |
- First Name: Antja-Voy
Last Name: Hartley Affiliation: DFCI - First Name: Simon
Last Name: Baldacci Affiliation: DFCI - First Name: Matthew
Last Name: Booker Affiliation: DFCI - First Name: Nathanael
Last Name: Gray Affiliation: Stanford Cancer Institute - First Name: Michael
Last Name: Tolsturokov Affiliation: DFCI - First Name: Pasi
Last Name: Janne Affiliation: DFCI
|
Abstract_Submission.pdf |
|
No |
Approved to be a Poster Presenter |
|
|
|
Mon, 03/11/2024 - 13:09 |
Arnaud |
Augert |
arnaud.augert@yale.edu |
|
Session 4: Small Cell Lung Cancer |
The chromatin remodeling complex PBAF functions as a bona fide tumor suppressor complex in SCLC |
Arnaud |
Augert |
Yale University |
|
Abstract_Submission.pdf |
|
No |
Approved to be a Speaker |
|
|
|
Mon, 03/11/2024 - 13:40 |
Kelly |
Becht |
kelly.becht@yale.edu |
(603) 401-2345 |
Session 2: Health Disparities in Lung Cancer |
Disparities in Stereotactic Radiosurgery Receipt in Patients with Brain Metastases from Non-Small Cell Lung Cancer |
Kelly |
Becht |
Department of Therapeutic Radiology, Yale School of Medicine |
- First Name: Meghan
Last Name: Lindsay Affiliation: Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine - First Name: Pamela
Last Name: Soulos Affiliation: Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine - First Name: James
Last Name: Hansen Affiliation: Department of Therapeutic Radiology, Yale School of Medicine - First Name: Charu
Last Name: Singh Affiliation: Department of Therapeutic Radiology, Yale School of Medicine - First Name: Yi
Last Name: An Affiliation: Department of Therapeutic Radiology, Yale School of Medicine - First Name: Sanjay
Last Name: Aneja Affiliation: Department of Therapeutic Radiology, Yale School of Medicine - First Name: Sarah
Last Name: Goldberg Affiliation: Department of Medicine, Section of Medical Oncology, Yale School of Medicine - First Name: Veronica
Last Name: Chiang Affiliation: Department of Neurosurgery, Yale School of Medicine - First Name: Henry
Last Name: Park Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
|
Abstract_Submission.pdf |
|
No |
Approved to be a Poster Presenter |
|
|
|
Sun, 03/10/2024 - 20:25 |
Alice |
Berger |
ahberger@fredhutch.org |
2066676281 |
Session 1: Oncogene-driven lung cancers and resistance to targeted therapies |
Systematic discovery of osimertinib resistance variants using CRISPR prime editing |
Alice |
Berger |
Fred Hutch |
|
Abstract_Submission.pdf |
|
No |
Approved to be a Speaker |
|
|
|
Wed, 03/06/2024 - 18:26 |
David |
MacPherson |
dmacpher@fredhutch.org |
2066676464 |
Session 4: Small Cell Lung Cancer |
In vivo functional screens identify drivers of chemoresistance in small cell lung cancer |
Scott |
Best |
Fred Hutch |
- First Name: Lauren
Last Name: Brumage Affiliation: Fred Hutch - First Name: Daniel
Last Name: Hippe Affiliation: Fred Hutch - First Name: Eli
Last Name: Grunblatt Affiliation: Fred Hutch - First Name: Pritha
Last Name: Chanana Affiliation: Fred Hutch - First Name: Feinan
Last Name: Wu Affiliation: Fred Hutch - First Name: Richard
Last Name: Ivey Affiliation: Fred Hutch - First Name: Jacob
Last Name: Kennedy Affiliation: Fred Hutch - First Name: Myung Chang
Last Name: Lee Affiliation: Genentech - First Name: Zhe
Last Name: Ying Affiliation: Fred Hutch - First Name: Ali
Last Name: Ibrahim Affiliation: Fred Hutch - First Name: Jae Heun
Last Name: Chung Affiliation: Fred Hutch - First Name: Anna
Last Name: Vigil Affiliation: Fred Hutch - First Name: Jackson
Last Name: Fatherree Affiliation: Fred Hutch - First Name: Slobodan
Last Name: Beronja Affiliation: Fred Hutch - First Name: Patrick
Last Name: Paddison Affiliation: Fred Hutch - First Name: Lucas
Last Name: Sullivan Affiliation: Fred Hutch - First Name: Amanda
Last Name: Paulovich Affiliation: Fred Hutch - First Name: Barzin
Last Name: Nabet Affiliation: Genentech - First Name: David
Last Name: MacPherson Affiliation: Fred Hutch
|
Abstract_Submission.pdf |
|
No |
Approved to be a Poster Presenter |
|
|
|
Mon, 03/11/2024 - 06:48 |
Elliott |
Brea |
elliott_brea@dfci.harvard.edu |
8479221042 |
Session 1: Oncogene-driven lung cancers and resistance to targeted therapies |
Development and effectiveness of TROP2 CAR T in EGFRm NSCLC including in TROP2 ADC refractory settings |
Elliott |
Brea |
DFCI |
- First Name: Eric
Last Name: Smith Affiliation: DFCI - First Name: David
Last Name: Barbie Affiliation: DFCI - First Name: Sachiv
Last Name: Chakravarti Affiliation: DFCI - First Name: Alexis
Last Name: Mottram Affiliation: DFCI - First Name: Prafulla
Last Name: Gokhale Affiliation: DFCI - First Name: Ken
Last Name: Ng Affiliation: DFCI - First Name: Cloud
Last Name: Paweletz Affiliation: DFCI - First Name: Pasi
Last Name: Jänne Affiliation: DFCI - First Name: Simon
Last Name: Baldacci Affiliation: DFCI - First Name: Elena
Last Name: Ivanova Affiliation: DFCI - First Name: Ha
Last Name: Vo Affiliation: DFCI - First Name: Tran
Last Name: Thai Affiliation: DFCI - First Name: Timothy
Last Name: Haggerty Affiliation: DFCI
|
Abstract_Submission.pdf |
|
No |
Approved to be a Poster Presenter |
|
|
|
Sun, 03/10/2024 - 23:49 |
Ling |
Cai |
ling.cai.30@gmail.com |
2146975362 |
Session 6: Cancer Biology |
A Lung Cancer Mouse Model Database |
Ling |
Cai |
Quantitative Biomedical Research Center, School of Public Health, University of Texas Southwestern Medical Center |
|
Abstract_Submission.pdf |
|
No |
Approved to be a Poster Presenter |
|
|
|
Mon, 03/11/2024 - 08:39 |
Jordan |
Cardenas |
jordan.cardenas@yale.edu |
3039196514 |
Session 3: Immuno-oncology |
The combination of modified IL-18 with anti-PD1 elicits a CD4+ T cell-mediated antitumor response in MHC Class I-deficient models of non-small cell lung cancer |
Jordan |
Cardenas |
Yale |
- First Name: Camila
Last Name: Robles-Oteiza Affiliation: Yale - First Name: Ting
Last Name: Zhou Affiliation: Yale - First Name: John
Last Name: Huck Affiliation: Yale - First Name: Paula
Last Name: Kavathas Affiliation: Yale - First Name: Aaron
Last Name: Ring Affiliation: Fred Hutch - First Name: Katerina
Last Name: Politi Affiliation: Yale
|
Abstract_Submission.pdf |
|
No |
Approved to be a Poster Presenter |
|
|
|
Fri, 03/08/2024 - 13:42 |
Sampada |
Chande |
sampada.chande@yale.edu |
6097722949 |
Session 6: Cancer Biology |
Characterization of tumor-neuron communication in lung adenocarcinoma brain metastasis |
Sampada |
Chande |
Department of Pathology, Yale University School of Medicine |
- First Name: Atsushi
Last Name: Yamasaki Affiliation: Daiichi Sankyo Co., Ltd., Tokyo, Japan - First Name: Don
Last Name: Nguyen Affiliation: Department of Pathology, Yale University School of Medicine
|
Abstract_Submission.pdf |
|
No |
Approved to be a Speaker |
|
|
|
Fri, 03/08/2024 - 13:42 |
Shi-Yong |
Sun |
ssun@emory.edu |
|
Session 1: Oncogene-driven lung cancers and resistance to targeted therapies |
Inhibition of hTERT/telomerase/telomere as an important mechanism mediating therapeutic efficacy of third generation EGFR inhibitors in EGFR mutant lung cancer |
Zhen |
Chen |
Emory University |
- First Name: Karin
Last Name: Vallega Affiliation: Emory University - First Name: Dongsheng
Last Name: Wang Affiliation: Emory University - First Name: Zhihan
Last Name: Quan Affiliation: Xiangya Second Hospital - First Name: Songqing
Last Name: Fan Affiliation: Xiangya Second Hospital - First Name: Qiming
Last Name: Wang Affiliation: Henan Cancer Hospital - First Name: Ticiana
Last Name: Leal Affiliation: Emory University - First Name: Ramalingam
Last Name: Suresh Affiliation: Emory University
|
Abstract_Submission.pdf |
|
No |
Approved to be a Poster Presenter |
|
|
|
Mon, 03/11/2024 - 09:20 |
Andrey |
Ivanov |
andrey.ivanov@emory.edu |
(404) 727-6343 |
Session 6: Cancer Biology |
The AVERON Notebook: a computational approach to druggable cancer dependencies enabled by mutant-directed protein-protein interactions. |
Hongyue (Nicole) |
Chen |
Emory University |
- First Name: Brian
Last Name: Revennaugh Affiliation: Emory University - First Name: Haian
Last Name: Fu Affiliation: Emory University - First Name: Andrey
Last Name: Ivanov Affiliation: Emory University
|
Abstract_Submission.pdf |
|
No |
Approved to be a Speaker |
|
|
|
Mon, 03/11/2024 - 13:38 |
Robert |
Matera |
robert.matera@yale.edu |
|
Session 4: Small Cell Lung Cancer |
Longitudinal tumor microenvironment analysis in dual checkpoint inhibitor blockade using ipilimumab/nivolumab in patients with advanced stage small cell lung cancer |
Anne |
Chiang |
Yale University / Smilow Cancer Center |
- First Name: Robert
Last Name: Matera Affiliation: Yale University / Smilow Cancer Center - First Name: Kerryan
Last Name: Ashley Affiliation: Yale University / Smilow Cancer Center - First Name: Barani
Last Name: Kumar Affiliation: Yale University / Smilow Cancer Center - First Name: Scott
Last Name: Gettinger Affiliation: Yale University / Smilow Cancer Center - First Name: Sarah
Last Name: Goldberg Affiliation: Yale University / Smilow Cancer Center - First Name: Roy
Last Name: Herbst Affiliation: Yale University / Smilow Cancer Center - First Name: Frederick
Last Name: Wilson Affiliation: Yale University / Smilow Cancer Center - First Name: Kurt
Last Name: Schalper Affiliation: Yale University / Smilow Cancer Center and Yale Department of Pathology
|
Abstract_Submission.pdf |
|
No |
Approved to be a Poster Presenter |
|
|
|
Sun, 03/10/2024 - 17:40 |
Jia |
Luo |
jia_luo@dfci.harvard.edu |
6176323000 |
Session 1: Oncogene-driven lung cancers and resistance to targeted therapies |
Clinicopathologic and genomic features of patients with mucinous lung adenocarcinoma and response to systemic therapies |
Alessandro |
Di Federico |
DFCI |
- First Name: Lingzhi
Last Name: Hong Affiliation: MDACC - First Name: Arielle
Last Name: Elkrief Affiliation: MSKCC - First Name: Rohit
Last Name: Thummalapalli Affiliation: MSKCC - First Name: Biagio
Last Name: Ricciuti Affiliation: DFCI - First Name: Joao
Last Name: Alessi Affiliation: DFCI - First Name: Pooja
Last Name: Gogia Affiliation: MSKCC - First Name: Federica
Last Name: Pecci Affiliation: DFCI - First Name: Malini
Last Name: Gandhi Affiliation: DFCI - First Name: Marc
Last Name: Ladanyi Affiliation: MSKCC - First Name: Jianjun
Last Name: Zhang Affiliation: MDACC - First Name: Don
Last Name: Gibbons Affiliation: MDACC - First Name: John
Last Name: Heymach Affiliation: MDACC - First Name: Mizuki
Last Name: Nishino Affiliation: DFCI - First Name: Lynette
Last Name: Sholl Affiliation: BWH - First Name: Mark
Last Name: Awad Affiliation: DFCI - First Name: Kathryn
Last Name: Arbour Affiliation: MSKCC - First Name: Adam
Last Name: Schoenfeld Affiliation: MSKCC - First Name: Natalie
Last Name: Vokes Affiliation: MDACC - First Name: Jia
Last Name: Luo Affiliation: DFCI
|
Abstract_Submission.pdf |
|
No |
Approved to be a Poster Presenter |
|
|
|
Mon, 03/11/2024 - 13:33 |
Darin |
Dolezal |
darin.dolezal@yale.edu |
203-584-4276 |
Session 6: Cancer Biology |
Brain metastasis Fibrosis Predicts Clinical Outcomes and Response to Treatment in Patients with Non-Small Cell Lung Cancer |
Darin |
Dolezal |
Yale School of Medicine - Department of Pathology |
- First Name: Sampada
Last Name: Chande Affiliation: Yale School of Medicine - First Name: Anna
Last Name: Arnal Estapé Affiliation: Yale School of Medicine - First Name: Sarah
Last Name: Goldberg Affiliation: Yale School of Medicine - First Name: Declan
Last Name: McGuone Affiliation: Yale School of Medicine - First Name: Veronica
Last Name: Chiang Affiliation: Yale School of Medicine - First Name: Don
Last Name: Nguyen Affiliation: Yale School of Medicine
|
Abstract_Submission.pdf |
|
Yes |
Approved to be a Poster Presenter |
|
|
|
Mon, 03/11/2024 - 14:46 |
Austin |
Draycott |
austin.draycott@yale.edu |
3475969754 |
Session 1: Oncogene-driven lung cancers and resistance to targeted therapies |
Dihydrouridine synthase 2 sustains levels of tRNACys to inhibit ferroptosis in lung cancer |
Austin |
Draycott |
Yale University |
- First Name: Matthew
Last Name: Wang Affiliation: Yale University - First Name: Diana
Last Name: Martínez Saucedo Affiliation: Yale University - First Name: Luisa
Last Name: Escobar-Hoyos Affiliation: Yale University - First Name: Wendy
Last Name: Gilbert Affiliation: Yale University
|
Abstract_Submission.pdf |
|
No |
Approved to be a Poster Presenter |
|
|
|
Mon, 03/11/2024 - 09:40 |
Francisco |
Exposito |
francisco.exposito@yale.edu |
|
Session 1: Oncogene-driven lung cancers and resistance to targeted therapies |
Investigating Lkb1 loss as novel synthetic vulnerability in EGFR-driven lung cancer |
Francisco |
Exposito |
Yale Cancer Center, New Haven; Yale School of Medicine, New Haven, USA |
- First Name: Emily
Last Name: Shuldiner Affiliation: Department of Biology, Stanford University, Stanford, California 94305, USA - First Name: Steven
Last Name: Lopez Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA - First Name: Minwei
Last Name: Wang Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA - First Name: Mariana
Last Name: Do Carmo Affiliation: Department of Pathology, Yale School of Medicine, New Haven, CT, USA - First Name: Laura
Last Name: Andrejka Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA - First Name: Giorgia
Last Name: Foggetti Affiliation: Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. - First Name: Christopher
Last Name: W. Murray Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA - First Name: Dimitri
Last Name: Petrov Affiliation: Department of Biology, Stanford University, Stanford, California 94305, USA - First Name: Monte
Last Name: Winslow Affiliation: Division of Oncology, Department of Medicine / Stanford Cancer Institute / Department of Pathology, Stanford University School of Medicine, Stanford, California - First Name: Katerina
Last Name: Politi Affiliation: Department of Pathology, Yale School of Medicine / Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
|
Abstract_Submission.pdf |
|
No |
Approved to be a Poster Presenter |
|
|
|
Mon, 03/11/2024 - 15:01 |
Janet |
Freeman-Daily |
janet.f-d@comcast.net |
253-606-2173 |
Session 1: Oncogene-driven lung cancers and resistance to targeted therapies |
Partnering with Patient Research Advocates |
Janet |
Freeman-Daily |
Fred Hutch SPORE (patient advocate) |
- First Name: Elda
Last Name: Railey Affiliation: Research Advocacy Network
|
Abstract_Submission.pdf |
|
No |
Approved to be a Speaker |
|
|
|
Fri, 03/08/2024 - 19:37 |
Boning |
Gao |
boning.gao@utsouthwestern.edu |
2146484915 |
Session 6: Cancer Biology |
New human cell line models for the study of pathogenesis of SARS-CoV-2 infection |
Boning |
Gao |
UT Southwestern |
- First Name: Ian
Last Name: Boys Affiliation: UT Southwestern - First Name: Sara
Last Name: El Zahed Affiliation: Icahn School of Medicine at Mount Sinai - First Name: Kimberley
Last Name: Avila Affiliation: UT Southwestern - First Name: Long Shan
Last Name: Li Affiliation: UT Southwestern - First Name: Luc
Last Name: Girard Affiliation: UT Southwestern - First Name: Hyunsil
Last Name: Park Affiliation: UT Southwestern - First Name: Victor
Last Name: Stastny Affiliation: UT Southwestern - First Name: Kenneth
Last Name: Huffman Affiliation: UT Southwestern - First Name: Shreoshi Pal
Last Name: Choudhuri Affiliation: UT Southwestern - First Name: Kimberly
Last Name: Batten Affiliation: UT Southwestern - First Name: Matthew
Last Name: Esparza Affiliation: UT Southwestern - First Name: Benjamin
Last Name: Drapkin Affiliation: UT Southwestern - First Name: Lisa
Last Name: Miorin Affiliation: Icahn School of Medicine at Mount Sinai - First Name: Jerry
Last Name: Shay Affiliation: UT Southwestern - First Name: Wendy
Last Name: Maury Affiliation: University of Iowa - First Name: Beatriz
Last Name: Fontoura Affiliation: UT Southwestern - First Name: John
Last Name: Schoggins Affiliation: UT Southwestern - First Name: Adolfo
Last Name: Garcia-Sastre Affiliation: Icahn School of Medicine at Mount Sinai - First Name: John
Last Name: Minna Affiliation: UT Southwestern
|
Abstract_Submission.pdf |
|
No |
Approved to be a Poster Presenter |
|
|
|